Hungary: No More Price Rises In 1997?

27 January 1997

Hungary's Welfare Ministry reports that producer and retail prices ofdrugs rose 12% on average on January 15, says MTI Econews. Unconfirmed reports say talks between drugmakers and distributors may mean an agreement for no further prices rises this year.

The Health Insurance Office has 85.6 billion forint ($521.5 million) to spend on drug price subsidies in 1997, against 81.85 billion forint in 1996. Drug prices rose 35% last year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight